Read about seven trends that will shape the innovations, therapies, & market landscape in oncology during 2026 & beyond.

Discover why Middlesex County, New Jersey, is a strategic choice for life sciences companies, with strong talent, research depth and site readiness to support innovation, manufacturing and long-term growth.

Cell therapy developers are under pressure to accelerate safety testing without compromising quality or regulatory compliance. Download today to learn how PCR-based mycoplasma and sterility testing can replace slow culture methods, delivering faster, more flexible, and more reliable results.

As biopharma manufacturers scale biologics to commercial production, choosing the right bioreactor size can determine long-term efficiency and cost. Download this free white paper to learn why 5,000L single-use bioreactors represent the commercial sweet spot for complex biologics—balancing flexibility, capacity, and economics.

Early-stage biologics don’t have time for trial-and-error. Download the free white paper to learn how a technology-driven approach—combining AI/ML, advanced cell line development, and intensified processes—can help you reach IND and first-in-human milestones faster.

A short industry brief on how CGT manufacturers can replace paper-based processes with scalable digital workflows—improving chain-of-identity tracking, accelerating batch release, and reducing delays that can impact patient treatment windows. Download the brief to see the roadmap.

Download this free infographic to see how life sciences teams can use privacy-first, HIPAA-compliant real-world data to build precise HCP and patient audiences, optimize campaigns in flight, and measure real outcomes—not just clicks.

Modern healthcare innovation goes beyond connecting systems—it requires an ecosystem approach that enables proactive, coordinated, and patient-focused engagement. This whitepaper explores how data, AI, and collaboration transform care delivery and outcomes. Download the free whitepaper to learn more.